Higher plasma levels of PCSK9 and hs-CRP lead to an earlier decline in left ventricular ejection fraction in myocardial infarction patients, further increasing the risk of myocardial infarction-induced heart failure (HF) and even death (140). The gene discussed is PCSK9; the disease is myocardial infarction.